An open-label study to evaluate the effect of PEGASYS on HBV-DNA and ALT normalization in patients with HBeAg positive chronic hepatitis B.
Phase of Trial: Phase IV
Latest Information Update: 26 Apr 2016
At a glance
- Drugs Peginterferon alfa-2a (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- Sponsors Roche
- 22 Mar 2016 Number of treatment arms changed from 1 to 2.
- 24 Jan 2012 Actual end date (Oct 2008) added as reported by ClinicalTrials.gov.
- 24 Jan 2012 Actual patient number is 150 according to ClinicalTrials.gov.